利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20080014200A1 Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents 审中-公开
联合治疗6,6-双环环取代杂双环蛋白激酶抑制剂和抗癌剂

Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
摘要：
The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an anti-cancer agent and an IGF1R inhibitor compound of Formula I combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The IGF1R inhibitor is represented by Formula I: wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein.
摘要（中）：

本发明提供了一种用于治疗患者的肿瘤或肿瘤转移的方法，其包括向所述患者同时或依次施用治疗有效量的抗癌剂和式I组合的IGF1R抑制剂化合物，其具有或不具有另外的试剂或 治疗，如其他抗癌药物或放射治疗。 IGF1R抑制剂由式I表示：其中X 1，X 2，X 3，X 4， X 5，X 6，X 7，R 1和Q 1， 在本文中定义。

公开/授权文献
信息查询
Global Dossier Espacenet
0/0